In Brief: Utah Medical Products/Vital Signs Inc.
This article was originally published in The Gray Sheet
Utah Medical Products/Vital Signs Inc.: Firms enter agreement under which Vital Signs will market Utah Medical's Deltran IV disposable blood pressure transducer (DPT) in the U.S. Manufactured via an automated process, the Deltran IV is a lower cost version of Utah Medical's hand-assembled Deltran II DPT, which is marketed in the U.S. by Baxter under the name Uniflow. The agreement follows Utah Medical's March announcement that it would seek new marketing partners for the Deltran line due to Baxter's decision to cut back its distribution of the Deltran II and to phase out distribution of Utah Medical's Summit DPT ("The Gray Sheet" March 11, I&W-7). The company notes that it may be nearing another marketing agreement for Deltran IV with a "significant medical monitoring equipment company in the U.S."...
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.